Compare CVS Health Corp (CVS) vs Vanguard Information Technology Index Fund ETF (VGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Vanguard Information Technology Index Fund ETF — how do they compare? CVS Health Corp trades at $93.5 (market cap $122.36B), while Vanguard Information Technology Index Fund ETF trades at $120.67. The key difference: CVS Health Corp pays a 2.78% dividend while Vanguard Information Technology Index Fund ETF pays none, and Vanguard Information Technology Index Fund ETF is trading nearer its 52-week high, CVS Health Corp nearer its low. Which is the better fit depends on your goals.
| CVS | VGT | |
|---|---|---|
Market Cap | $122.36B | — |
Sector | Health | — |
52-Week High | $110.60 | $125.77 |
52-Week Low | $65.51 | $83.59 |
Enterprise Value | $184.71B | — |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
VGT, the Vanguard Information Technology ETF, trades at $121.45, up 1.55% on the day, with a strong bullish technical signal from moving averages. The ETF provides concentrated exposure to major U.S. technology stocks, particularly benefiting from the AI infrastructure build-out. Recent institutional buying activity from firms like Bank of America and Baron Financial Group highlights continued confidence.
The outlook for VGT remains positive, driven by secular tech trends and AI investment, though risks include high concentration in top holdings and sector-specific volatility. The ETF's low-cost structure and pure-play tech focus present a compelling opportunity for long-term growth investors, but its performance is heavily tied to the fortunes of a few mega-cap companies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →
